1151 related articles for article (PubMed ID: 25595712)
21. Proteomic responses of HepG2 cell monolayers and 3D spheroids to selected hepatotoxins.
Hurrell T; Lilley KS; Cromarty AD
Toxicol Lett; 2019 Jan; 300():40-50. PubMed ID: 30381255
[TBL] [Abstract][Full Text] [Related]
22. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array.
Tung YC; Hsiao AY; Allen SG; Torisawa YS; Ho M; Takayama S
Analyst; 2011 Feb; 136(3):473-8. PubMed ID: 20967331
[TBL] [Abstract][Full Text] [Related]
23. Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells.
Baek N; Seo OW; Lee J; Hulme J; An SS
Drug Des Devel Ther; 2016; 10():2155-65. PubMed ID: 27445462
[TBL] [Abstract][Full Text] [Related]
24. Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance.
Lu HF; Chua KN; Zhang PC; Lim WS; Ramakrishna S; Leong KW; Mao HQ
Acta Biomater; 2005 Jul; 1(4):399-410. PubMed ID: 16701821
[TBL] [Abstract][Full Text] [Related]
25. The Neuro-spheroid--A novel 3D in vitro model for peripheral nerve regeneration.
Kraus D; Boyle V; Leibig N; Stark GB; Penna V
J Neurosci Methods; 2015 May; 246():97-105. PubMed ID: 25769275
[TBL] [Abstract][Full Text] [Related]
26. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
Loessner D; Rizzi SC; Stok KS; Fuehrmann T; Hollier B; Magdolen V; Hutmacher DW; Clements JA
Biomaterials; 2013 Oct; 34(30):7389-400. PubMed ID: 23827191
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
28. Toxicity and anti-prolific properties of Xysmalobium undulatum water extract during short-term exposure to two-dimensional and three-dimensional spheroid cell cultures.
Calitz C; Hamman JH; Viljoen AM; Fey SJ; Wrzesinski K; Gouws C
Toxicol Mech Methods; 2018 Nov; 28(9):641-652. PubMed ID: 29873580
[TBL] [Abstract][Full Text] [Related]
29. Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model.
Elje E; Mariussen E; Moriones OH; Bastús NG; Puntes V; Kohl Y; Dusinska M; Rundén-Pran E
Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32197356
[TBL] [Abstract][Full Text] [Related]
30. The two faces of titanium dioxide nanoparticles bio-camouflage in 3D bone spheroids.
Souza W; Piperni SG; Laviola P; Rossi AL; Rossi MID; Archanjo BS; Leite PE; Fernandes MH; Rocha LA; Granjeiro JM; Ribeiro AR
Sci Rep; 2019 Jun; 9(1):9309. PubMed ID: 31249337
[TBL] [Abstract][Full Text] [Related]
31. The effect of dimensionality on growth and differentiation of neural progenitors from different regions of fetal rat brain in vitro: 3-dimensional spheroid versus 2-dimensional monolayer culture.
Lu H; Searle K; Liu Y; Parker T
Cells Tissues Organs; 2012; 196(1):48-55. PubMed ID: 22301365
[TBL] [Abstract][Full Text] [Related]
32. Spheroid model for functional osteogenic evaluation of human adipose derived stem cells.
Gurumurthy B; Bierdeman PC; Janorkar AV
J Biomed Mater Res A; 2017 Apr; 105(4):1230-1236. PubMed ID: 27943608
[TBL] [Abstract][Full Text] [Related]
33. Scaffold-free formation of a millimeter-scale multicellular spheroid with an internal cavity from magnetically levitated 3T3 cells that ingested iron oxide-containing microspheres.
Lee JH; Hur W
Biotechnol Bioeng; 2014 May; 111(5):1038-47. PubMed ID: 24254251
[TBL] [Abstract][Full Text] [Related]
34. Decrease of reactive oxygen species-related biomarkers in the tissue-mimic 3D spheroid culture of human lung cells exposed to zinc oxide nanoparticles.
Kim E; Jeon WB; Kim S; Lee SK
J Nanosci Nanotechnol; 2014 May; 14(5):3356-65. PubMed ID: 24734552
[TBL] [Abstract][Full Text] [Related]
35. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery.
Leite PEC; Pereira MR; Harris G; Pamies D; Dos Santos LMG; Granjeiro JM; Hogberg HT; Hartung T; Smirnova L
Part Fibre Toxicol; 2019 Jun; 16(1):22. PubMed ID: 31159811
[TBL] [Abstract][Full Text] [Related]
36. Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.
Li X; Zhang X; Zhao S; Wang J; Liu G; Du Y
Lab Chip; 2014 Feb; 14(3):471-81. PubMed ID: 24287736
[TBL] [Abstract][Full Text] [Related]
37. 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.
Daunys S; Janonienė A; Januškevičienė I; Paškevičiūtė M; Petrikaitė V
Adv Exp Med Biol; 2021; 1295():243-270. PubMed ID: 33543463
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture.
Alwahsh M; Al-Doridee A; Jasim S; Awwad O; Hergenröder R; Hamadneh L
Mol Biol Rep; 2024 Jun; 51(1):721. PubMed ID: 38829450
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.
Sirenko O; Hancock MK; Hesley J; Hong D; Cohen A; Gentry J; Carlson CB; Mann DA
Assay Drug Dev Technol; 2016 Sep; 14(7):381-94. PubMed ID: 27494736
[TBL] [Abstract][Full Text] [Related]
40. Phosphate-enhanced cytotoxicity of zinc oxide nanoparticles and agglomerates.
Everett WN; Chern C; Sun D; McMahon RE; Zhang X; Chen WJ; Hahn MS; Sue HJ
Toxicol Lett; 2014 Feb; 225(1):177-84. PubMed ID: 24362007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
